CD-P-PH/PHO - Database and publications
melclass database
Recommendations on the classification of medicines and their supply conditions: available in the Melclass database
Evidence-based classification reviews
- Evidence-based reviews of medicines belonging to the ATC group D04A and Naloxone (2022)
- Evidence-based reviews of medicines belonging to the ATC groups S01GA and S01GX (2022)
- Evidence-based reviews of medicines belonging to the ATC group R05DA and Doxylamine (2021)
- Evidence-based reviews of medicines belonging to the ATC group R05DB (2021)
- Evidence-based reviews of medicines belonging to the ATC group D07A (2019)
- Evidence-based reviews of medicines belonging to the ATC group N02B (2019)
- Evidence-based reviews of medicines belonging to the ATC group R01 (2019)
- Evidence-based reviews of medicines with various ATC codes (2019)
- Evidence-based reviews of medicines belonging to the ATC group G01AF and Promethazine (2017)
- Evidence-based reviews of medicines belonging to the ATC groups A02BA and A02BC (2016)
Survey reports
Survey report “New trends as regards the supply modes of medicines” 2020
online access
If you wish to know the classification of a medicine in a particular country or the CD-P-PH/PHO’s recommendation on the prescription status and related supply conditions of a medicine, you can do so via the
Additional information
past events
20-21 November 2014, Zagreb, Croatia
OTC Medicines: the role of good classification practices in promoting medication safety and accessibility in Europe
- Download the press release
- Download the Workshop report